To measure changes in NPM-ALK fusion genes and fusion gene transcripts under minimal disease conditions, ALK- negative DG-75 cells were added to the ALK+ ALCL cells for a dilution of 1:100. This evidence concerns the gene ALK and anaplastic large cell lymphoma.